Randox Diagnostics: Leading the Field in Equine Health
We wouldn’t be the experts in Equine Health we are without our team of highly knowledgeable and experienced veterinary scientists.
Dr. Sarah Gildea, Senior R&D Scientist at Randox Teoranta in Dungloe, Co. Donegal, Ireland, has a BSc Equine Health, a PhD in Equine Influenza Virus, and spent many years working in the Virology Unit of The Irish Equine Centre prior to joining our team.
‘Randox Diagnostics: Leading the Field in Equine Health’
by Dr. Sarah Gildea BSc PhD, Senior R&D Scientist at Randox
“With over 30 years’ experience, Randox is a leading specialist in the development of veterinary diagnostic solutions. Our extensive product portfolio includes diagnostic reagents, quality controls, external quality assessment (RIQAS) and the Rx series of clinical chemistry analysers which are specifically designed to monitor the general health and well-being of a diverse range of animal species.
“Long established in the equine market, our clinical chemistry analysers provide the largest and most comprehensive test menu available and are used extensively to monitor the health and nutritional status of horses all around the world. In addition, our clinical chemistry tests can also be used for therapeutic drug monitoring, assessing reproductive fitness and as an indirect method in the diagnosis of certain equine diseases/conditions.
“Equine infectious anaemia (EIA) otherwise known as “swamp fever” is a viral disease affecting horses which can cause intermittent fever, anaemia, emaciation and eventual death. Although the disease is not always fatal, infected horses can become disease carriers thus posing a significant risk to other equines. Hence, rapid diagnosis is of fundamental importance. In a study carried out in Romania where the virus is endemic, a novel link between oxidative stress (measuring Total Antioxidant Status, Superoxide Dismutase and Glutathione Peroxidase) and EIA viral infection was established (Bolfă PF et al., 2012). The assessment of oxidative-antioxidative status in blood has also been investigated for a variety of other equine diseases and a correlation between oxidant-antioxidant imbalance and exercised induced pulmonary haemorrhage (Mills and Higgins, 1997), equine motor neuron disease (Delguste et al., 2007), recurrent airway obstruction (Deaton et al., 2006), joint disease (Dimock et al., 2000), endometritis and colic (Krumrych et al., 2013) has been identified. Such findings highlight the broader use of clinical chemistry tests in studying the pathogenesis and pathomechanisms of equine diseases.
“The increased participation of equine athletes in different sports and disciplines has resulted in a rise in the incidence of joint problems, with osteoarthritis now a common finding among performance horses. Similar to all athletes, the equine appendicular skeleton is under extreme pressure when participating in any intense physical training or equestrian events. Although some horses may remain clinically unremarkable, such physical exertion can result in various inflammatory disorders with subsequent increased risk of injury. Analysis of total protein in joint synovial fluid using the Randox Rx series of clinical chemistry analysers plays an important role in the study of equine orthopaedics worldwide and in the identification of appropriate therapeutic tools to enhance healing. The measurement of other well established biomarkers e.g. Total Antioxidant Status, Superoxide Dismutase, Serum Amyloid A and Creatine Kinase in monitoring response to exercise, transport, trauma and stress have all been previously reported using Randox technology and the results well documented in the scientific literature.
“In addition, using our clinical chemistry analysers, the measurement of seminal plasma antioxidant activity has been demonstrated as a useful indicator of semen quality and subsequent reproductive capability in performance stallions. In a study carried out by Härtlová et al., (2013) stallions experiencing induced sport workload stress were found to have higher levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) compared to those without workload stress. A correlation between an increased level of these intracellular enzymes in seminal plasma and defects in the spermatozoa membrane has previously been established (Katila, 2001).
“Randox is also actively involved in the development of tests for the detection of performance enhancing substances in horses. Such testing protects the safety and welfare of these animals and ensures that competitions are won primarily on merit. This testing is performed not only using our innovative Biochip Array Technology but also our Rx series of clinically chemistry analysers. During prolonged strenuous exercise, racehorses can experience acidemia. In an effort to enhance racing performance “bicarbonate loading” by trainers was first identified in the early 1990s and since then some racing authorities have identified a limit of total carbon dioxide (TC02) concentration which is permissible in horses prior to competition. A comparative study carried out in Australia which examined the capability of four clinical chemistry analysers (Beckman Synchron EL-ISE®, Beckman Synchron CX®5, Beckman UniCel DxC®600, Randox DaytonaTM) to measure TC02 in equine plasma reported that the Randox Daytona offered a high degree of accuracy and precision when compared to the gold standard. Of important logistical consideration however, this study identified the Randox Daytona as the only instrument sufficiently “portable” to allow TC02 testing to be carried out not only in a laboratory but also “onsite” at a racetrack in a laboratory vehicle (Jarrett et al., 2010).
“So as you can see – for all your equine needs from general health screening, monitoring response to exercise or injury, identifying suitable therapeutics and their appropriate threshold, studying the pathogenesis and pathomechanisms of certain equine diseases and assessing reproductive fitness – the Randox Rx series offers it all.”
For more information about our work in the area of Equine Health, please contact randoxpr@randox.com
References
Bolfă, PF., et al. (2012) Oxidant-antioxidant imbalance in horses infected with equine infectious anaemia virus . Vet J 2012, 192: 449-454
Deaton, CM., et al (2006) Comparison of the antioxidant status in tracheal and bronchoalveolar epithelial lining fluids in recurrent airway obstruction. Equine Vet J 2006, 38: 417-422
Delguste, C et al., (2007) Change in blood antioxidant status of horses moved from a stable following diagnosis of equine motor neuron disease . Can Vet J 2007, 48: 1165-1167
Dimock, AN., et al (2000) Evidence supporting an increased presence of reactive oxygen species in the diseased equine joint. Equine Vet J 2000, 32: 439-443
Härtlová, H., et al. (2013) Semen quality, lipid peroxidation, and seminal plasma antioxidant status in horses with different intensities of physical exercise. Acta Vet Brno 2013, 82: 031–035
Jarrett, M (2010): Alternative instrumentation for the analysis of total carbon dioxide (TC02) in equine plasma. Anal Bioanal Chem 2010, 397: 717-722
Katila, T (2001): In vitro evaluation of frozen-thawed stallion semen: A review. Acta Vet Scand 2001, 42: 199-217
Krumrych, W., et al. (2013) Oxidant/antioxidant status assessment of blood in selected equine diseases. Bull Vet Inst Pulawy 2013, 57: 225-230
Mills PC and Higgins AJ (1997) Oxidant injury, nitric oxide and pulmonary vascular function: implications for the exercising horse. Vet J 1997, 153: 125-148
We Are Randox | Randox Placement Student Meghan Semple receives Ulster Business School Excellence in Placement Award
At Randox we take pride in the high calibre of placement students we have as part of our team.
Not only do our students develop their business knowledge and acumen while they work here, they also grow personally during their year with us.
The acquisition of skills including time management, problem-solving and professional conduct goes hand-in-hand with the development of confidence, self-esteem and assertiveness.
And just as our students benefit from their times spent with us, so too do we as a modern and innovative healthcare company benefit from the fresh perspectives and forward-thinking ideas our students bring to Randox.
These students make real and valued contributions to our global organisation, and no one seems to demonstrate this better than our Business Placement Student of the Year 2015-2016, Meghan Semple.
Meghan joined Team Randox in September 2015 as a Marketing Placement Student from Ulster University Business School.
Fast forward just over a year, and Meghan has received a Highly Commended Marketing Award from The Ulster University Business School, at the Excellence in Placement Awards, as recognition of the contributions she has made to Randox!
Speaking at the Excellence in Placement Awards, she explained why.
“When I joined Randox last year I was appointed a Marketing role in the RX Series, which are Randox’s range of clinical chemistry analysers.
“For the first few weeks in my new role I spent time getting to know the brand, and making sure to gain an in-depth understanding of its key communication channels and messages.
“The RX Series was already present online in the form of a website, social media platforms, and through various mail campaigns. However, I identified the company’s potential for higher engagement and better recognition as a leading technology brand, by conducting some competitor analysis and thoroughly researching our own perception amongst our target audience.
“This resulted in an opportunity to present a content marketing strategy to Marketing Management. This included strict guidelines to ensure consistency through all graphics, language used and tone of voice. I also managed the implementation of this content marketing strategy via mail-campaigns, social platforms, web pages, insightful clinical market articles and whitepapers.
“In November 2015 my strategy was implemented, increasing online engagement by a staggering 1,200%. We also increased our web traffic by 256.91%. By quarter 3 of 2016, 100% of RX sales to distributors and end-users came from my Digital Marketing campaign.
“My work within the RX Series holistically changed the face of the brand, and for my efforts I was awarded the Pinnacle Business Placement Student of the Year award from Randox.”
Eamon Lenehan, Global Marketing Manager from Randox, commented;
“The effect Meghan had on the RX Series business is extremely impressive given the short time she was with us. Her input in to our online presence cannot be underestimated and her dedication to increasing our band awareness has had a considerable impact on the Randox brand.
Our digital presence has never been stronger, and that is thanks to Meghan. Her creation of creative and original content as well as her collaboration across all channels has truly injected a new lease of life in to the RX Series and subsequently in to the Randox brand as a whole.”
We are extremely grateful to Meghan for all her hard work during her placement year at Randox and are equally proud of her achievements at the Ulster University Business School Excellence in Placement Awards.
The positive changes seen throughout the company are testament to the value of student placements and we are proud to be a key student employer within Northern Ireland. In fact, this year, we had our largest ever intake on our placement and graduate programmes, with 71 new team members having started work with us in September.
And it’s easy to see why so many students and graduates choose to come to Randox.
Meghan continued;
“There is only so much you can learn within the walls of your university classroom. What’s most important is putting that knowledge and learning in to practice in a work environment. When I started Randox I had 2 years of university studies under my belt, but I still hadn’t decided what area of marketing I wanted to go into.
“From working in Randox I have found my passion. The team there were so supportive – their trust and encouragement is what enabled me to get so involved in the company’s digital marketing activities.
“With their guidance I was truly able to make a huge impact within the RX Series brand and I felt as much a part of the team as the full-time members of staff.
“I would highly recommend taking a placement year with Randox. There is no better way to learn how a global organisation operates than to work in one, and I am confident that my time there will help me secure a full-time job when I graduate. If I could do my year with Randox all over again, then I would!”
Congratulations Meghan, we’re delighted to have been able to join you at your awards ceremony yesterday!
For more information about the Excellence in Placement Awards, or about placement opportunities at Randox, please contact randoxpr@randox.com
Make sure to follow Randox on Facebook, Twitter and Instagram to stay up-to-date with the hashtag #WeAreRandox for more stories about the amazing team we have here!
Pictured at the Ulster University Business School Excellence in Placement Awards are;
(L-R) Randox Global Marketing Manager Eamon Lenehan, Randox Business Placement Student of the Year Meghan Semple and Randox Human Resources Officer Jolene Jamison.
NHS cancer testing service at ātipping pointā
A stark warning has been issued this week by Cancer Research UK (CRUK) that NHS cancer testing services are at tipping point, caused by increased demand and a lack of capacity.
Tackling this is essential, according to pathology expert Professor Manual Salto-Tellez, “We need to act now before this situation gets worse. It’s vital that patients are diagnosed at an early stage when treatment is more likely to be successful.”
CRUK says the UK’s cancer survival falls behind that of other European countries and is urging an improvement in early diagnosis through diagnostic services. The importance of this is emphasised by estimates from the charity that cancer diagnoses in the UK will rise from 352,000 (2013) to 500,000 (2035).
According to the report:
- One in two people will develop cancer at some point in their lifetime
- Well-resourced testing services are crucial to early diagnosis of cancer which in turn is vital to increase survival rates
- Up to 70% of clinical decisions are based on diagnostic testing
- Pathology numbers are not growing to meet rising demand for tests
Emma Greenwood, Cancer Research UK’s director of policy, said;
“Diagnostic services, including pathology, urgently need support and investment to ensure that diagnoses aren’t delayed and patients benefit from the latest treatment. The diagnostic bottleneck will only get worse without action now and this involves addressing staff shortages in imaging, endoscopy and pathology.”
A Department of Health spokesperson said, “Early and fast diagnosis is crucial in improving patient outcomes and experience. Getting pathology test results to patients quickly is a key part of this. That’s why we have invested over £2.5bn on efficient and robust pathology services across the NHS.”
Following the publication of the report Dr Martin Crockard, Head of Molecular R&D at Randox, said;
“As populations continue to age, illnesses like cancer, stroke, diabetes and cardiovascular disease will become more common. We know this is going to have a huge impact on healthcare systems but what is yet to be determined is how they will respond.
“Currently 70% of clinical decisions are using in-vitro diagnostics and that will likely increase – therefore it’s essential that pathology services are fully supported. Better diagnostics enables clinicians to make evidence-based decisions, which delivers improved patient outcomes.”
For more information regarding our preventive health philosophy please contact our PR team via email: randoxpr@randox.com
Randox celebrates Women in STEM at Armagh Planetarium Ask A Scientist Event
“Have you always known that you wanted to be an Engineer?”
“Is there opportunity for career progression and promotion within Engineering?”
“So you do for the Randox machines what app developers do for smartphones?”
These were just some of the astute and intriguing questions posed by students of Dungannon Integrated College, Drumcree College Portadown, and St Ciaran’s Ballygawley, to our Randox Software Engineer, Ciara Shaw, at Armagh Planetarium’s Ask A Scientist Event on Friday 18th November.
The event took place as part of Science Week 2016, organised by the Science Foundation Ireland, and the day took the format of a Speed Networking session. Students each spent 10 minutes chatting with a scientist, asking them all the questions they’ve ever wanted to know about careers in STEM, and then moved on to the next candidate!
This year the event had a particularly exciting twist – all the scientists involved were women!
Ciara was one of a group of nine women with a career in STEM – science, technology, engineering and maths – who took the time to meet with the students in attendance to chat to them about working in STEM.
As a hard-working and proud engineer, Ciara took the opportunity to inspire young women to take up STEM subjects for their GCSEs and A-Levels.
Currently, only 9% of the UK’s engineering and technology workforce is made up of women, a statistic which Ciara highlighted in her key note speech at the Ask A Scientist event.
Following the event, she commented;
“I’ve always been interested in IT and Engineering and so it surprises me that only 9% of the engineering and technology workforce in the UK is made up of women. I wanted to showcase to the pupils at the Ask A Scientist Event today that working in STEM is an exciting and valid career choice for women as much as it is for men. At Randox alone there are opportunities to work across a wide range of STEM disciplines – software developers and testers, IT support, engineers, research scientists, mathematicians working in finance and accounts…the list goes on. I hope that through today’s event I was able to encourage some pupils to choose to study STEM subjects at school, so that they can aspire to these jobs in their future.”
Chatting to the pupils in their Q&A sessions, Ciara found the pupils had aspirations in abundance.
“One pupil told me they wanted to be an Orthopaedic Surgeon, and another said they were going to be an Architectural Engineer. It was amazing getting the chance to listen to their hopes and plans for the future, and hopefully by answering their questions, helping them get on the path to achieving their goals.”
Joining Ciara at the event were representatives from the CSI Service of the PSNI; Siobhan Stevenson, Head of Collections Care at National Museums Northern Ireland; Kerry, Heather and Sam, Education Support Officers at the Armagh Planeatarium; and a number of PhD students currently carrying out their research at Armagh Observatory, including Eliceth Rojas-Montes, who gave a key note speech on her astronomy research.
Each scientist was able to provide the students with an insight into their line of work, and similarly share their experiences and knowledge with the other scientists!
Juie Shetye, PhD student at Armagh Observatory, said she was delighted to be able learn about different areas of science from the other scientists and engineers.
And Ciara agreed.
“Each area of science is so niche that our areas of work are worlds apart,” she commented.
“It’s been an extremely enjoyable day celebrating the work of Women in STEM and being positive role models for young women considering a job in the STEM industries.”
For more information about this event please contact our PR team via email: randoxpr@randox.com
For current STEM vacancies at Randox, please visit our Careers website.
We Are Randox | Randox Rugby Team take to the pitch for inaugural match against Randalstown
Our Randox Rugby team have been hard at work in training in advance of their first ever competitive match against Randalstown!
On Wednesday the team comprised of Cathal Kelly, Robin Walsh, Charlie Spon-Smith, David Craig, Johnny Acheson, Christopher Stevenson, Peter FitzGerald, Jack Hanna and Jason Webster, played their inaugural match against a Randalstown select team under the floodlights of Randox’s rugby pitch in Crumlin.
Heavy rain in the days leading up to game-night threatened to postpone the match but the rain held off and in mild conditions with little wind, it provided the perfect night for running rugby, and the match didn’t disappoint!
Months of hard work had prepared the young Randox team for the match against the more experienced Randalstown team. With training and exercise drills weekly, the men from Randox had been put through their paces and were ready for some competitive rugby!
Jason Webster, Randox Health Sales Manager, who plays for our Randox Rugby Team, commented;
“The Randox men more than held their own in what was an open, end-to-end game. Right up until the last minute the win could have gone to either team – it was a nail-biting match!”
The Randalstown team showed their rugby skill and rugby know-how with excellent ball retention in the first half of the rugby mach. They earned hard yards with their big forwards punching holes around the tackle area, which resulted in an early lead, but the speed and individual ability of our Randox players produced some mouth-watering tries of their own!
The final score of the match was an unbelievably close 37-39 to Randalstown.
What an incredible score for our team’s first match against a rugby club team! Our Randox rugby players gave the Randalstown boys a good run for their money, and had great fun while doing so!
Jason continued;
“The camaraderie between all the men from both Randox and Randalstown was fantastic and it was great to see such great sportsmanship from both teams. We hope to have another game against Randalstown in the coming weeks – bring your A-game Randalstown!”
Spectators at the match included Dr. Peter FitzGerald, Nuailin FitzGerald, supporting members of staff from Randox and a contingent of staff and players from Randalstown RFC.
Thank you to everyone who turned out to support our Randox Rugby team and of course to the Randalstown players for a great game!
For more information about our Randox Rugby Team contact Jason Webster via email: Jason.webster@randoxhealth.com
Make sure to follow Randox on Facebook, Twitter and Instagram to stay up-to-date with the hashtag #WeAreRandox for more stories about the amazing team we have here!
World Antibiotic Awareness Week at Randox
The global crisis of antimicrobial resistance is never far from the headlines. As part of World Amicrobial Awareness Week, we’ve been discussing the dangers and importantly the work being done to combat this growing threat.
There’s a very simple reason why we must all do what we can to tackle AMR. This year it’s thought 700,000 people died from drug resistant illnesses such as bacterial infections, malaria, HIV/Aids or tuberculosis. Experts warn that by 2050, this figure will rise to 10million.
Randox’s aim is to revolutionise global healthcare and we are committed to combating the threat of antibiotic resistance. We have a number of tests on the market that can help the fight against AMR, strengthen consumer confidence and ensure quality and safety for a number of different industries. So to round off this week, we spoke to two of our experts at Randox: Business Development Manager, Dr Mary Jo Kurth, and Molecular Diagnostics Manager, Dr Martin Crockard.
70% GP’s have been reported to prescribe antibiotics when they don’t know whether the infection is caused by the virus or bacteria.
At the frontline of the battle to curb AMR are the GPs but they’re not able to access the latest technology which can help them. Dr Mary Jo Kurth said, “In the current GP setting, diagnostic testing to determine whether a respiratory infection is bacterial or viral is unavailable, and therefore doctors often have to guess – or feel pressurised into prescribing antibiotics because patients demand it. However antibiotics only work to treat bacterial infections and are useless in treating infections that are caused by viruses.
“The consequences are severe. Medical procedures like organ transplantation and cancer chemotherapy need antibiotics to prevent and treat the bacterial infections that can be caused by the treatment. Without effective antibiotics, even routine operations could become high risk procedures if serious infections can’t be treated. The hard won victories against infectious diseases of the last fifty years will be jeopardized.”
Our Biosciences division have developed a test that can rapidly detect and identify the cause of 22 respiratory infections, in both the upper and lower respiratory tract, and therefore subsequently determine if an antibiotic is required as well as then identify the most effective antibiotic to take. Additionally our Confidante kit – the world’s first over-the-counter home sexual health test – can detect ten of the most common STIs with one patient sample and deliver accurate and reliable results securely and discreetly within one week. This takes the guesswork out of antibiotic prescription and could go a long way in fighting the antibiotic resistance crisis.
Dr Martin Crockard said, “Identifying the specific cause of illnesses provides opportunities to tailor treatment, reducing antibiotic misuse. Not all infections respond to antibiotics, however a multiplex approach which identifies bacterial, viral or fungal pathogens encourages improved clinical decision-making, refining treatment, leading to enhanced patient care.
“The molecular group here at Randox are developing a range of multiplex infection detection arrays to identify specific infection agents, allowing more appropriate use of antibiotics to improve patient care and reduce the onset of antibiotic resistance.”
In addition to tackling AMR via medical settings, there is work that can be done to deal with it in our food. Randox Food Diagnostics offer a comprehensive range of diagnostic solutions to allow for the detection and quantification of antibiotic residues within animal and food products. With validation across a range of matrices Randox Food allows producers to ensure their products are free from antibiotic residues.
As consumer awareness develops so does the need for antibiotic screening within agriculture and food production. Guaranteeing an antibiotic-free product strengthens consumer confidence and ensures food integrity on a global scale. Randox Food offers the Evidence Investigator matched with biochip array technology to provide the end user with fast, reliable results to ensure antibiotic free produce.
The UK Government recently commissioned a two year review into the crisis. Led by Lord Jim O’Neill, the final report outlined a new system of ‘market entry rewards’ worth $1.6 billion to the successful developer of a new antibiotic, which meets a prospectively-defined criteria of ‘unmet need’. Developers of alternative therapies aimed at tackling areas where there is unmet need due to rising AMR would also be eligible for these rewards. Such rewards would be paid after a successful product comes to market.
Chief Medical Officer, Dame Sally Davies said, “Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. That’s why governments and organisations across the world, including the World Health Organization and G8, need to take this seriously.
“This is not just about government action. We need to encourage more innovation in the development of antibiotics – over the past two decades there has been a discovery void around antibiotics, meaning diseases have evolved faster than the drugs to treat them.”
AMR will not go away on its own. It requires complex and comprehensive action across many sectors.
If you are interested in finding out more information, please visit randox.com
ISO 22870- Are you meeting expectations?
Quality control has recently become crucial in the Point-of-Care (POC) field due to the introduction of ISO 22870 regulations and increased focus in patient safety. Quality control is critical in reducing turnaround time and saving money.
There is now an international standard specifically for POC testing, ISO 22870. This standard is intended to be used in conjunction with the standard for medical laboratories, ISO 15189. This means that aspects relating to Point-of-Care such as training, competence and documentation should be carefully planned, implemented and governed by a quality management system and there is a requirement for QC and EQA to be performed, where available.
POCT is typically carried out by non-laboratory staff, therefore when selecting the appropriate IQC material for POCT there are a number of key characteristics you must consider;
- Format of the material – QC material employed should be liquid stable, requiring no preparation, reducing the likelihood of human error and increasing convenience.
- Value assignment – all values must be accurately assigned. Look out for suppliers who use a large number of independent labs to determine the target value.
- Third party controls – manufactured independently from any specific instrument or method third party controls are designed to deliver unbiased performance assessment.
- Storage – for convenience controls should be liquid stable, as these can be easily stored in a fridge at 2oC – 8oC and won’t need to be shipped on dry ice.
- Stability – a control with a good open vial stability will mean that it can be used for longer with less waste produced, meaning it is more convenient for the medical professional to use.
- Transportation– the liquid stable controls can be conveniently stored at 2oC – 8oC reducing the need to ship on dry ice
- Minimal training– easy to use with little training required, therefore suitable for use by non-laboratory personnel
In addition to IQC, External Quality Assessment (EQA) must also be employed to ensure a comprehensive review of test system performance. It is best to select a programme that offers frequent reporting with a large database of users. This will enable rapid error identification and ultimately accurate and reliable patient testing.
Our Acusera liquid ready-to-use controls include:
- Blood Gas Control– A liquid stable control provided in easy to open ampoules for added convenience and ease-of-use. Assayed, method specific target values are provided for the most common blood gas instruments.
- Liquid Cardiac Control– This is a highly convenient liquid stable cardiac control offering excellent consistency. Assayed, instrument specific target values are provided for 8 cardiac markers, enabling flexibility and consolidation.
- Liquid Urinalysis Control– Liquid control that is compatible for use with both manual and automated methods of dipstick analysis. Available in convenient 12ml vials or 25ml dropper bottles with assayed ranges provided for 13 parameters covering the chemical examination of urine specimens.
- Liquid HbA1c Control– This is another highly convenient liquid ready-to-use control. With an open vial stability of 30 days, keeping waste and costs to a minimum.
Complementary EQA programmes are also available to meet the needs of ISO 22870.
Randox Trade Mission to Massachusetts
A delegation led by the Cathaoirleach of Donegal County Council, Cllr Terence Slowey and the Mayor of Derry City and Strabane District Council, Cllr Hilary McClintock, are in Massachusetts this week as part of a joint endeavour to build relationships and forge partnerships.
Randox joined representatives from a wide range of sectors including education, food and drink distribution and manufacturing to attend meetings with a range of business contacts across the State of Massachusetts and key influencers.
Randox also made a number of key technology and business visits to Harvard and the State House and will participate in the Golden Bridges Conference.
Randox Senior Manager Mark Campbell said;
“The US is one of Randox’s most important markets and we are delighted to participate in this joint trade mission. There is clearly a strong regional and cultural link with Massachussets, and with facilities in Co Antrim and Co Donegal we seek to further develop our business relationship and increase exports. Our innovative diagnostic technologies have much to offer this US high tech hub – and will allow us to create further employment at home.”
In 2015 Randox announced plans to invest €25 million in Randox Teoranta, located in Dungloe in County Donegal. The investment included increasing staff numbers to 540 by 2020, offering world class careers in state-of-the-art R&D and manufacturing facilities. Randox also unveiled the Randox Science Park which will become the prime manufacturing and R&D facility in the UK. This new state of the art facility will generate 540 high value job opportunities over the next four years and will accelerate the development of new products into a wide range of clinical needs. These include various cancers, stroke, heart disease and neurodegenerative disorders, through more efficient, high specification manufacturing and the provision of state-of-the-art R&D laboratories.
Randox founder and CEO Dr Peter FitzGerald said;
“Our vision is to revolutionise healthcare through continuously improving diagnostic solutions. As well as employing locally we want to draw top class talent back to Donegal from the wider Irish diaspora and establish better relationships with the wider Massachusetts area. Randox offers world leading career opportunities to life scientists, electrical and mechanical engineers and software developers, and a chance to join a pioneering team creating diagnostic tests and analyser systems that save lives across the world.”
For more information on the delegation in Massachusetts please contact Randox PR via email: randoxpr@randox.com
We Are Randox | Meet our award-winning Costume Designer, Monika!
At Randox we pride ourselves on being a global company with an international team of over 1400 people from 145 different countries.
Our dedicated workforce have a range of talents and skills that they bring with them to Randox each day. But the commitment and dedication of our hard-working workforce doesn’t end when they leave the office. Randox employees have a wide range of hobbies and interesting talents and we are delighted to be able to share some of these with you through our We Are Randox series.
Recently Monika, one of our valued Manufacturing and Despatch Operatives at Randox took the time to tell us about her passion for designing and creating unique handmade costumes for Festivals found throughout Northern Ireland.
Here is Monika’s story:
“I joined Randox in Northern Ireland roughly about 5 months ago as a Manufacturing and Despatch Operative in our Mivan site based in Crumlin. I was really happy to land a job within an international organisation that employed a wide range of people from different cultures and different backgrounds.
Back in Poland, where I am originally from, I studied full time for 6 years in the OSSP Art School. For as long as I can remember I have always been interested in arts and crafts so it came naturally to me when I first started to design costumes.
I prefer to design my own original work and not copy anyone else’s designs. My favourite type of costumes to design are ancient religious characters from past centuries and eras. As there is no proof or documentation which illustrates what they ‘should’ look like, it gives me free reign to be as creative as I want to be. Nobody is able to say whether your design is right or wrong, you can only imagine what it is supposed to look like.
There are a variety of different festivals and competitions that I am able to enter including the MCM Comic Con and the Show Master competition. The first competition that I entered here in Northern Ireland was the MCM Comic Con in 2015 which takes place every year in Belfast. It takes me roughly around 100 hours to make one costume as they are all handmade so it takes a lot of time, effort and dedication. This festival attracts about 16,000 people each time so I was thrilled to win first place the first time that I entered!
The winning design I created was an old European folklore costume that the judges loved. This encouraged me to enter the summer MCM Comic competition which took place in July. I designed an Aztec God costume for this entry and ended up coming in at first place again which was a great achievement. I was presented with a trophy and money voucher when I won both of these competitions which was great.
The next competition that I hope to enter is the 2017 MCM Comic Con competition which is set to take place in March. For the March competition I am designing a Witch Doctor outfit and I am intrigued to see what way the final design will turn out.
I’m a fully qualified artist and every costume I design I can sell on under my brand name – Eliot Von Valentino – but they are all quite expensive.
Everything I create is handmade using materials such as leather which is extremely costly. I had to skin my leather sofa once to get the amount of leather that I needed to create my design!
I also use natural gem stones which are all individually sewed on. I take a lot of pride in my designs and I finance them all myself which is sometimes difficult as the materials needed to complete my designs are so expensive and hard to come by.
In the future I have high aspirations to enter the bigger competitions that take place in London. They draw in crowds of 120,000 so it would be a good opportunity to showcase my work to such a large scale audience.”
We look forward to seeing Monika’s latest design this coming March for her next competition. Good Luck Monika!
If you are interested in joining the multi-talented and passionate team we have here at Randox please visit our careers page for current vacancies.
Make sure to follow Randox Careers on Facebook, Twitter and Instagram to stay up-to-date with the hashtag #WeAreRandox
The UK Government is being urged to ban excessive use of antibiotics in farming
To coincide with the start of World Antibiotic Awareness Week the UK Government is being urged to ban excessive use of antibiotics in farming by a group of leading doctors, according to The Daily Telegraph.
Made up of 12 royal medical colleges, the British Medical Association and the Faculty of Public Health, the group say that the UK should “use the opportunity afforded by Brexit to lead the world in banning” preventative prescription of medicines on animals.
A decision made by the European Parliament earlier this year to ban mass agricultural medication has not yet been ratified by member states or the European Commission.
A Department of Environment, Food and Rural Affairs’ spokesman told the newspaper that dealing with AMR is a “top priority” though the paper notes it ‘stopped short of promising a ban.’
In 2015 McDonalds set itself a two year deadline to stop its US restaurants buying chicken raised with human antibiotics. It led to one of the US’s leading meat producers – Tyson Foods – promising to end the practice by September 2017 – which is, as The Guardian stated, “one of the most aggressive timelines yet set by an American poultry company.” The company’s CEO Donnie Smith told the newspaper: “We have found as we have reduced the level of antibiotics we use, whether it’s human use or vet-only, our cost has actually gone down. A lot of the ways we’ve been able to accomplish this is by working with our farmers on better husbandry practices. If this millennial mum wants a no-antibiotic ever..nugget we better supply that.”
Farmers Weekly reported this month on a Danish Crown initiative launched in 2015 whereby pig farmers attach an antibiotics-free tag to piglets at the neonatal stage. It’s removed at any point if antibiotic treatment is deemed necessary. It claims that although early farm trials suggest a production fall of up to 2.5 piglet per sow per year, the “premium covers additional costs if 35% or more piglets carry the tag to the slaughterhouse.”
Pig farmer Stine Mikkelsen carried out a major review of hygiene and health on her farm to reduce antimicrobial use to boost revenue by £11.25 per pig. She says that although production is down and labour costs did increase, it “feels good” to farm in this way. She told the newspaper, “I am very motivated to do something about it – it’s a hard route to take but I have a good feeling about this system.”
Randox Food Diagnostics is working with global leaders in the food industry to tackle antibiotic resistance and safeguard their use for both human and veterinary treatment.
Using a dedicated research and development team, Randox have the ability to respond rapidly to emerging new drugs of abuse and regulations in relation to food and animal safety, with sixty-five new residue drug targets are currently in development to keep up with the ever changing market of food safety. Randox Food Diagnostics are ensuring that all residue screening laboratories requirements are met by providing reliable food safety screening on a global scale.
On top of the food safety product range Randox Food also offer a range of analysers, reagents and test kits for use throughout the winemaking process to ensure quality is maintained in every bottle.
This product range includes the RX misano semi-automated wine analyser and the RX Monaco fully automated wine analyser.
For more information on what we do, please visit: www.randoxfood.com
The RX misano is currently unavailable to purchase in Germany